Technical Analysis for AGLE - Aeglea BioTherapeutics, Inc.

Grade Last Price % Change Price Change
grade F 6.48 -5.68% -0.39
AGLE closed down 5.68 percent on Friday, May 17, 2019, on 53 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical AGLE trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup -5.68%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -5.68%
Up 3 Days in a Row Strength -5.68%
Earnings Movers Other -5.12%
MACD Bullish Signal Line Cross Bullish -4.85%
Lower Bollinger Band Walk Weakness -4.85%
Earnings Movers Other -4.85%
Outside Day Range Expansion -4.85%
Lower Bollinger Band Touch Weakness -4.85%

Older signals for AGLE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Aeglea Biotherapeutics, Inc., a biopharmaceutical company, engages in developing engineered human enzymes for the treatment of inborn errors of metabolism and cancer. It develops AERase/AEB1102, an amino acid for the degradation of arginine in the circulation, as well as for the treatment of hyperargininemia and cancer; and AECase/AEB3103, an engineered and PEGylated human cysteine/cystine degrading enzyme that increases oxidative stress through glutathione depletion for treatment of hematologic and solid malignancies. The company also engages in developing AEMase/AEB2109, an engineered human enzyme that degrades methionine for the treatment of solid tumors; and AEB4104, an engineered human enzyme that degrades homocysteine in the circulation for the treatment of inborn error of metabolism homocystinuria. It has a strategic partnership with KBI Biopharma. Aeglea Biotherapeutics, Inc. was formerly known as Aeglea BioTherapeutics Holdings, LLC. The company was founded in 2013 and is based in Austin, Texas.
Chemistry Biopharmaceutical Cancer Solid Tumors Organic Chemistry Inborn Errors Of Metabolism
Is AGLE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.0
52 Week Low 6.31
Average Volume 173,879
200-Day Moving Average 8.4097
50-Day Moving Average 7.5526
20-Day Moving Average 6.9365
10-Day Moving Average 6.785
Average True Range 0.3431
ADX 38.88
+DI 12.3904
-DI 27.271
Chandelier Exit (Long, 3 ATRs ) 6.5307
Chandelier Exit (Short, 3 ATRs ) 7.4493
Upper Bollinger Band 7.4666
Lower Bollinger Band 6.4064
Percent B (%b) 0.07
BandWidth 15.284365
MACD Line -0.2506
MACD Signal Line -0.2628
MACD Histogram 0.0122
Fundamentals Value
Market Cap 106.61 Million
Num Shares 16.5 Million
EPS -1.81
Price-to-Earnings (P/E) Ratio -3.58
Price-to-Sales 15.71
Price-to-Book 1.22
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.16
Resistance 3 (R3) 7.22 7.05 7.05
Resistance 2 (R2) 7.05 6.87 7.02 7.01
Resistance 1 (R1) 6.76 6.77 6.68 6.71 6.97
Pivot Point 6.59 6.59 6.55 6.56 6.59
Support 1 (S1) 6.31 6.42 6.22 6.25 5.99
Support 2 (S2) 6.14 6.31 6.11 5.95
Support 3 (S3) 5.85 6.14 5.91
Support 4 (S4) 5.80